Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,500 | 90,300 | 97,000 | 107,700 | 89,000 |
| Receivables | 111,500 | 110,200 | 104,800 | 132,800 | 131,900 |
| Inventories | 150,600 | 142,700 | 138,100 | 138,800 | 161,900 |
| Other current assets | 0 | 0 | 0 | 0 | 73,900 |
| TOTAL | $351,400 | $356,000 | $352,400 | $393,400 | $472,600 |
| Non-Current Assets | |||||
| PPE Net | 115,400 | 114,300 | 109,800 | 110,700 | 109,500 |
| Intangibles | 516,400 | 486,600 | 563,100 | 567,900 | 1,015,200 |
| Other Non-Current Assets | 84,500 | 82,100 | 82,500 | 82,200 | 58,900 |
| TOTAL | $716,300 | $683,000 | $755,400 | $760,800 | $1,183,600 |
| Total Assets | $1,067,700 | $1,039,000 | $1,107,800 | $1,154,200 | $1,656,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,400 | 9,400 | 9,400 | 9,400 | 9,400 |
| Accounts payable and accrued liabilities | 54,200 | 48,800 | 46,000 | 54,300 | 54,200 |
| Accrued Expenses | 74,800 | 66,000 | 71,400 | 91,300 | 82,700 |
| Other current liabilities | N/A | N/A | N/A | N/A | 52,900 |
| TOTAL | $147,900 | $134,600 | $137,200 | $165,900 | $212,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 93,400 | 95,700 | 98,000 | 125,300 | 152,600 |
| Other Non-Current Liabilities | 42,100 | 26,100 | 27,600 | 29,000 | 37,100 |
| TOTAL | $141,800 | $128,100 | $131,200 | $159,800 | $213,600 |
| Total Liabilities | $289,700 | $262,700 | $268,400 | $325,700 | $426,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,419 | 46,402 | 46,244 | 46,003 | 45,957 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -778,600 | -777,200 | -700,400 | -707,000 | -309,700 |
| Other shareholders' equity | -32,600 | -31,900 | -42,500 | -44,600 | -36,800 |
| TOTAL | $778,000 | $776,300 | $839,400 | $828,500 | $1,229,700 |
| Total Liabilities And Equity | $1,067,700 | $1,039,000 | $1,107,800 | $1,154,200 | $1,656,200 |